Archives of Virology

, Volume 82, Issue 1–2, pp 19–29 | Cite as

The biological relationship of mouse hepatitis virus (MHV) strains and interferon:In vitro induction and sensitivities

  • L. E. GarlinghouseJr.
  • A. L. Smith
  • T. Holford
Original Papers


Five prototype strains of mouse hepatitis virus (MHV) -1,-3, -S,- A59 and -JHM were analyzed for their ability to induce interferon (IFN) in seven cell lines of rodent origin. Induction of IFN by all of the prototype MHV strains was infrequent and unpredictable, while IFN was produced consistently by five cell lines treated with known inducers. Priming and/or aging of cells did not enhance IFN induction by the MHV strains except in the case of MHV-A59 which consistently induced moderate levels of IFN on L-cells which were both primed and aged. Kinetic studies of MHV-A59-induced IFN on primed and aged L-cells demonstrated that detectable levels of IFN were not produced until 24 hours post-inoculation (p.i.). Peak levels were attained at 30 hours p.i. with no additional IFN produced through 48 hours p.i. MHV-induced IFN was similar in composition and properties to Newcastle disease virus-induced IFN.

The sensitivities of the five MHV strains to eight concentrations of preformed L-cell IFN were also assessed. All strains except MHV-S fit a linear model with MHV-3, MHV-A59 and MHV-JHM having similar slopes. At most concentrations MHV-3 was less sensitive than MHV-1, -A59 or -JHM to IFN. The response curve for MHV-S was non-linear. This strain was more sensitive to the antiviral effects of the pre-formed IFN except at the highest concentrations of IFN used.


Hepatitis Infectious Disease Linear Model Interferon Response Curve 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Abreu, S. L., Banoroft, F. C., Stewart II, W. E.: Interferon Priming effects on interferon messenger RNA. J. Biol. Chem.254, 4114–4118 (1978).Google Scholar
  2. 2.
    Bang, F. B., Warwick, A.: Mouse macrophages as host cells for the mouse hepatitis virus and the genetic base of their susceptibility. Proc. Nat. Acad. Sci. U.S.A.46, 1065–1075 (1960).Google Scholar
  3. 3.
    Baron, S., Dianzani, F., Stanton, G. J.: The interferon system: A review to 1982—Part 1. Texas Rept. on Biol. Med.41, 64–98 (1982).Google Scholar
  4. 4.
    Cantell, K., Pauker, K.: Quantitative studies on viral interference in suspended L-cells. IV. Production and assay of interferon. Virology21, 11–21 (1963).Google Scholar
  5. 5.
    Dubois-Dalcq, M. E., Doller, E. W., Haspel, M. V., Holmes, K. V.: Cell tropism and expression of mouse hepatitis viruses (MHV) in mouse spinal cord cultures. Virology119, 317–331 (1982).Google Scholar
  6. 6.
    Goto, N., Hirano, N., Aivchi, M., Hayashi, T., Fujiwara, K.: Nasoencephalopathy of mice infected intranasally with a mouse hepatitis virus, JHM strain. Jpn. J. Exp. Med.47, 59–64 (1977).Google Scholar
  7. 7.
    Hirano, N., Goto, N., Makino, S., Fujiwara, K.: Persistent infection with mouse hepatitis virus, JHM strain in DBT cell culture. Adv. Exp. Med. Biol.142, 301–308 (1981).Google Scholar
  8. 8.
    Hsiung, G. D., Fong, C. K. Y.: Diagnostic Virology, 245–251. New Haven: Yale Press 1982.Google Scholar
  9. 9.
    Kawade, Y., Yamamoto, Y.: Induction and production of L-cell interferon. Meth. Enzymol.78, 139–143 (1981).Google Scholar
  10. 10.
    Kawai, A., Matsumoto, S., Tanabe, K.: Characterization of rabies viruses recovered from persistently infected BHK cells. Virology67, 520–533 (1975).Google Scholar
  11. 11.
    Knobler, R. L., Haspel, M. V., Oldstone, M. B. A.: Mouse hepatitis virus type 4 (JHM strain)-induced fatal central nervous system disease. J. Exp. Med.153, 832–843 (1981).Google Scholar
  12. 12.
    Kraft, L. M.: Viral diseases of the digestive system. In:Foster, H. L., Small, J. D., Fox, J. G. (eds.), The Mouse in Biomedical Research, Vol. II: Diseases, 159–193. New York: Academic Press 1982.Google Scholar
  13. 13.
    Kronenberg, L. H., Friedman, T.: Relative quantitative assay on the biological activity of interferon messenger RNA. J. gen. Virol.27, 225–232 (1975).Google Scholar
  14. 14.
    MacNaughton, M. R., Patterson, S.: Mouse hepatitis virus strain 3 infection of C57, A/Sn and A/J strain mice and their macrophages. Arch. Virol.66, 71–75 (1980).Google Scholar
  15. 15.
    Morgensen, S. C.: Role of macrophages in natural resistance to virus infections. Microbiol. Rev.43, 1–26 (1979).Google Scholar
  16. 16.
    Pickel, K., Muller, M. A., ter Meulen, V.: Analysis of age-dependent resistance to murine coronavirus JHM infection in mice. Infect. Immun.34, 648–654 (1981).Google Scholar
  17. 17.
    Reed, J., Muench, H.: A simple method of estimating fifty percent end points. Am. J. Hyg.27, 493–496 (1938).Google Scholar
  18. 18.
    Robb, J. A., Bond, C. W.: Coronaviridae. In:Fraenkel-Conrat, H., Wagner, R. R. (eds.), Comprehensive Virology, Vol. 14, 193–247. New York: Plenum Press 1979.Google Scholar
  19. 19.
    Rubinstein, S., Familletti, P. C., Pestka, S.: Convenient assay for interferons. J. Virol.37, 755–758 (1981).Google Scholar
  20. 20.
    SAS Institute Inc: SAS User's Guide: Statistics. Cary, N.C.: SAS Institute Inc. 1982.Google Scholar
  21. 21.
    Schindler, L., Engler, H., Kirchner, H.: Activation of natural killer cells and induction of interferon after injection of mouse hepatitis virus type 3 in mice. Infect. Immun.35, 869–873 (1982).Google Scholar
  22. 22.
    Schmidt, N. J.: Cell culture techniques for diagnostic virology. In:Lennette, E. H., Schmidt, W. V. (eds.), Diagnostic Procedures for Viral, Rickettsial and Chlamydial Infections, 5th ed., 65–140. Washington, D.C.: American Public Health Association 1979.Google Scholar
  23. 23.
    Siddel, S., Wege, H., ter Meulen, V.: The biology of coronaviruses. J. gen. Virol.64, 761–776 (1983).Google Scholar
  24. 24.
    Smith, A. L., Tignor, G. H.: Host cell receptors for two strains of Sindbis virus. Arch. Virol.66, 11–26 (1980).Google Scholar
  25. 25.
    Stewart II, W. E., Gosser, L. B., Lockert, jr., R. Z.: Distinguishing characteristics of the interferon responses of primary and continuous mouse cell cultures. J. gen. Virol.13, 35–50 (1971).Google Scholar
  26. 26.
    Stohlman, S. A., Weiner, L. P.: Stability of neurotropic mouse hepatitis virus (JHM strain) during chronic infection of neuroblastoma cells. Arch. Virol.57, 53–61 (1978a).Google Scholar
  27. 27.
    Stohlman, S. A., Sakaguchi, A. Y., Hiti, A.: Interferon production and activity in mouse neuroblastoma cells. Arch. Virol.57, 91–96 (1978b).Google Scholar
  28. 28.
    Stohlman, S. A., Frelinger, J. A., Weiner, L. P.: Resistance to fatal central nervous system disease by mouse hepatitis virus, strain JHM-II. Adherent cell-mediated protection. J. Immunol.124, 1733–1739 (1980).Google Scholar
  29. 29.
    Stohlman, S. A., Brayton, P. R., Harmon, R. C., Stevenson, D., Ganges, R. G., Matsushima, G. K.: Natural killer cell activity during mouse hepatitis virus infection: Response in the absence of interferon. Intl. J. Cancer31, 309–314 (1983).Google Scholar
  30. 30.
    Virelizier, J. L., Dayan, A. D., Allison, A. C.: Neuropathological effects of persistent infection of mice by mouse hepatitis virus. Infect. Immun.12, 1127–1140 (1975).Google Scholar

Copyright information

© Springer-Verlag 1984

Authors and Affiliations

  • L. E. GarlinghouseJr.
    • 1
    • 2
  • A. L. Smith
    • 1
    • 2
  • T. Holford
    • 2
  1. 1.Section of Comparative MedicineYale UniversityNew HavenUSA
  2. 2.Department of Epidemiology and Public Health, School of MedicineYale UniversityNew HavenUSA

Personalised recommendations